Fig. 2.
The mean number of recorded anti-vascular endothelial growth factor units dispensed for the final persistent ranibizumab and aflibercept cohorts at month 6 (a) and month 12 (b)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.